Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Foster Jonathan P., holds the title of Chief Financial Officer at Moleculin Biotech, Inc..
On 2026-11-16, the insider transacted 451 shares.The shares were transacted at a weighted average price of $1.41 per share, resulting in a total market-relevant value of $635.46.
Foster Jonathan P. (Chief Financial Officer) had withheld for taxes $635 of $MBRX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.